Health Justice and Innovation
The Health Justice and Innovation Grant Program is an initiative of West Support, aimed at addressing structural healthcare inequality by supporting innovative therapeutic development and scientific research. The program focuses on diseases that disproportionately affect vulnerable populations and seeks to enhance accessibility to affordable, scalable medical interventions.
Program Goals
-
To support the development of therapies for high-burden diseases with limited treatment options.
-
To promote solutions suitable for use in low-resource and conflict-affected environments.
-
To enable the right to health through scientific innovation and rights-based approaches.
-
To build partnerships between medical developers and global social impact networks.
-
To accelerate access to new medical technologies for populations underserved by mainstream health systems.
Who Can Apply
The program welcomes proposals from:
Clinical-stage biopharmaceutical or medical technology companies;
Academic institutions or research centers;
Registered non-profit organizations engaged in health innovation;
Public-private partnerships in the health sector;
Interdisciplinary consortiums involving scientists, clinicians, and civil society actors.
Applicants must demonstrate a commitment to equitable access, transparency, and evidence-based impact.
Priority Focus Areas
Grant proposals will be considered under the following thematic directions:
-
Therapeutic innovation for neglected or high-burden diseases (e.g., liver cirrhosis, oncology, post-infectious complications).
-
Solutions suitable for decentralized or home-based care, including injectable therapies and mobile treatment models.
-
Biotechnology and delivery platforms that improve accessibility, stability, or cost-effectiveness.
-
Applied clinical research aimed at real-world implementation in fragile or underserved health systems.
-
Integration of health equity frameworks in the design and delivery of treatment programs.
Health Justice
and Innovation
Grants program
Through the Health Justice and Innovation Grants program, West Support advances the right to health by supporting medical research and therapeutic development that reduce structural disparities in healthcare access. Grants are awarded to efforts targeting populations affected by systemic exclusion from quality treatment, including those in low-resource, conflict-affected, or underserved regions.
🎯 Program Goals
-
To support the development of therapies for high-burden diseases with limited treatment options.
-
To promote solutions suitable for use in low-resource and conflict-affected environments.
-
To enable the right to health through scientific innovation and rights-based approaches.
-
To build partnerships between medical developers and global social impact networks.
-
To accelerate access to new medical technologies for populations underserved by mainstream health systems.
👥 Who Can Apply
The program welcomes proposals from:
-
Clinical-stage biopharmaceutical or medical technology companies;
-
Academic institutions or research centers;
-
Registered non-profit organizations engaged in health innovation;
-
Public-private partnerships in the health sector;
-
Interdisciplinary consortiums involving scientists, clinicians, and civil society actors.
Applicants must demonstrate a commitment to equitable access, transparency, and evidence-based impact.
🧭 Priority Focus Areas
Grant proposals will be considered under the following thematic directions:
-
Therapeutic innovation for neglected or high-burden diseases (e.g., liver cirrhosis, oncology, post-infectious complications).
-
Solutions suitable for decentralized or home-based care, including injectable therapies and mobile treatment models.
-
Biotechnology and delivery platforms that improve accessibility, stability, or cost-effectiveness.
-
Applied clinical research aimed at real-world implementation in fragile or underserved health systems.
-
Integration of health equity frameworks in the design and delivery of treatment programs.
⏱️ Program Timeline
-
Call opens: July 1, 2025
-
Application deadline: July 21, 2025
-
Review period: July 21 – August 1, 2025
-
Notifications of award: August 1, 2025
-
Funding begins: August 2, 2025
💵 Funding and Grant Amounts
-
Total available funding: $5,000,000 USD
-
Individual grant size: To be determined based on project scope and merit
-
Disbursement: In 2–3 installments, tied to agreed milestones
-
Eligible costs: R&D expenses, clinical testing, technology validation, regulatory preparation, access strategy design
📊 Selection Criteria
All applications will be evaluated based on the following dimensions:
CriterionWeight
Scientific and technical merit30%
Relevance to health equity20%
Feasibility and scalability20%
Organizational capacity15%
Monitoring and impact framework15%
📂 Required Documents
-
Completed application form
-
Technical proposal (max 10 pages)
-
Project budget
-
Timeline with milestones
-
Legal proof of organizational registration
-
CVs of key personnel